ProCE Banner Activity


Which HIV PrEP for Which Patient? Black MSM


In this case-based video module, learn the latest data and recommendations for determining which HIV PrEP options are most appropriate for MSM, including for those desiring nondaily options, while also considering the barriers and facilitators in the PrEP care cascade for Black MSM.

Pharmacists: 0.25 contact hour (0.025 CEUs)

Nurses: 0.25 Nursing contact hour

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Released: October 18, 2022

Expiration: October 17, 2023

No longer available for credit.



Latesha Elopre

Latesha Elopre, MD, MSPH

Scientific and Medical Consultant
Associate Professor of Medicine
Division of Infectious Diseases
Assistant Dean for Diversity and Inclusion
Medical Education
University of Alabama at Birmingham
Birmingham, Alabama

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from

ViiV Healthcare

Target Audience

This program is intended for physicians, pharmacists, registered nurses, nurse practitioners, physician associates/physician assistants, and other healthcare professionals who care for patients who may be candidates for PrEP.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Select the most appropriate PrEP regimen for each patient by comparing and contrasting regimen characteristics and data from clinical trials and patient-reported outcomes


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure

Primary Author

Latesha Elopre, MD, MSPH

Scientific and Medical Consultant
Associate Professor of Medicine
Division of Infectious Diseases
Assistant Dean for Diversity and Inclusion
Medical Education
University of Alabama at Birmingham
Birmingham, Alabama

Latesha Elopre, MD, MHSP: researcher: Merck Sharp & Dohme.

Staff Disclosure


Jessica L. Adams, PharmD, AAHIVE

Scientific Director, Infectious Diseases
Clinical Care Options
New York, United States

Jessica Adams, PharmD, BCPS, has no relevant financial relationships to disclose.

Geet Asnani,

Geet Asnani has no relevant financial relationships to disclose.

Ian Murphy, PhD

Ian Murphy, PhD, has no relevant financial relationships to disclose.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant financial relationships to disclose.

Julie Skowronski, FNP-BC

Julie Skowronski, FNP-BC, has no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hours.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 0.25 contact hours (0.025 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-259-H02-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 100% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Additional Information

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from October 18, 2022, through October 17, 2023:

1. Register online at
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.



The goal of this activity is to improve learners’ competence in making evidence-based decisions regarding the choice of HIV PrEP regimen for appropriate candidates.